Tarsus Pharmaceuticals Logo

Tarsus Pharmaceuticals

🇺🇸
TARS
US87650L1035

Tarsus Pharmaceuticals is a US-based biopharmaceutical company dedicated to developing innovative therapeutic solutions for eye care. The company focuses on addressing conditions like Demodex blepharitis by utilizing advanced, science-based approaches to improve patient outcomes in ophthalmology.

Next Quarterly Earnings

Tuesday, November 10, 2026
CW 46
Pre-Market
In 75 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 13, 2026

Stock Price

Frequently asked questions

When will Tarsus Pharmaceuticals report its next quarterly earnings?

Tarsus Pharmaceuticals is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Tarsus Pharmaceuticals last report quarterly earnings?

Tarsus Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.43 USD.

How does Tarsus Pharmaceuticals stock react to earnings?

Across its last 3 earnings reports, Tarsus Pharmaceuticals stock moved by ±5.2% on average the following day. The largest reaction was +7.8% on 02/23/2026; 2 of 3 reactions were positive.

How often has Tarsus Pharmaceuticals beaten expectations?

Tarsus Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the Tarsus Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.55
Actual:
Q2 2026
Missed
Estimate:-$0.19
Actual:-$0.43
Difference:-$0.24
Price reaction (1 day):+6.6 %
Price reaction (7 days):+12.4 %
Q1 2026
Beat
Estimate:-$0.39
Actual:-$0.16
Difference:+$0.23
Price reaction (1 day):-1.2 %
Price reaction (7 days):-0.2 %
Q4 2025
Missed
Estimate:-$0.09
Actual:-$0.20
Difference:-$0.11
Price reaction (1 day):+7.8 %
Price reaction (7 days):+11.3 %
Q2 2025
Beat
Estimate:-$0.33
Actual:-$0.30
Difference:+$0.03
Q1 2025
Missed
Estimate:-$0.36
Actual:-$0.48
Difference:-$0.12

Earnings statistics

Stock reaction to earnings

±5.2%
Avg. next-day move
+7.8%
Largest move (02/23/2026)
66.7%
Share of positive reactions
±7.9%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-36.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Tarsus Pharmaceuticals
Ticker Symbol
TARS
ISIN
US87650L1035
Country
🇺🇸
USA
Sector